Victory Capital Management Inc Accelerate Diagnostics, Inc Transaction History

Victory Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$7.49 - $15.16 $42,745 - $86,518	-5,707 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$4.62 - $18.74 $8,925 - $36,205	-1,932 Reduced 25.29%	5,707 $48,000
Q4 2019 Feb 06, 2020	BUY	$14.6 - $18.13 $26,703 - $33,159	1,829 Added 31.48%	7,639 $129,000
Q4 2019 Feb 04, 2020	SELL	$14.6 - $18.13 $1,080 - $1,341	-74 Reduced 1.26%	5,810 $98,000
Q3 2019 Nov 12, 2019	BUY	$16.62 - $23.92 $97,792 - $140,745	5,884 New	5,884 $109,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $133M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.